Screening rules
Why it screened this way
✗
No hard-rule violations detected.
USHealthcareIndia
Regeneron Pharmaceuticals, Inc.
Cautious₹762
We can't fully confirm this stock yet — it needs a manual check by a scholar or compliance expert.
92/100
Cautious
We can't fully confirm this stock yet — it needs a manual check by a scholar or compliance expert.
Market Cap₹80,543
Revenue₹14,343
Total Debt₹2,706
Debt / Mcap3.73%
Non-Halal Income4.99%
SectorHealthcare
Price Chart
Loading chart...
Multi-Methodology Screening
Screened against 4 international Shariah standards
ConsensusCautious0/4 pass
S&P Shariah IndicesCautious
Debt Ratio3.7%/ 33.0%
Non-Halal Income5.0%/ 5.0%
Interest Income5.0%/ 5.0%
Receivables7.1%/ 33.0%
Cash & IB Securities21.2%/ 33.0%
SectorAllowed
AAOIFI StandardsCautious
Debt Ratio6.7%/ 30.0%
Non-Halal Income5.0%/ 5.0%
Interest Income5.0%/ 5.0%
Receivables14.2%/ 49.0%
Cash & IB Securities21.2%/ 30.0%
SectorAllowed
FTSE Yasaar (Maxis)Cautious
Debt Ratio6.7%/ 33.0%
Non-Halal Income5.0%/ 5.0%
Interest Income5.0%/ 5.0%
Receivables14.2%/ 50.0%
Cash & IB Securities21.2%/ 33.0%
SectorAllowed
Khatkhatay Independent NormsNon-Compliant
Debt Ratio6.7%/ 25.0%
Non-Halal Income5.0%/ 5.0%
Interest Income5.0%/ 5.0%
Receivables14.2%/ 100.0%
Cash & IB Securities21.2%/ 10.0%
SectorAllowed
Interest income is 5.0% of revenue, exceeding the 3% limit under Independent.
Cash & interest-bearing securities are 21.2% of total assets, exceeding the 10% limit under Independent.
Each methodology uses different denominators and thresholds. A stock may be compliant under one standard but not another. The consensus reflects the majority verdict across all three.
Compliance check
Green = safe, amber = close to limit, red = over the limit
Debt level
3.73%Current debt
3.36%Income purity
4.99%Interest earned
4.99%Similar stocks
Other stocks in Healthcare